Table III.
Prognostic value of p-STAT3 (immunohistochemistry) using univariate analysis.
DFS
|
OS
|
|||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
All | ||||
Tumour p-STAT3 ordinala | 0.84 (0.68–1.04) | 0.10 | 0.83 (0.63–1.08) | 0.16 |
Tumour p-STAT3 binary (positive vs. negative) | 0.72 (0.51–1.04) | 0.08 | 0.75 (0.48–1.18) | 0.21 |
Stroma p-STAT3 ordinala | 0.85 (0.68–1.05) | 0.13 | 0.88 (0.67–1.15) | 0.34 |
Stroma p-STAT3 binary (positive vs. negative) | 0.78 (0.55–1.08) | 0.14 | 0.79 (0.52–1.21) | 0.28 |
ER+/HER2− | ||||
Tumour p-STAT3 ordinala | 0.80 (0.63–1.01) | 0.06 | 0.83 (0.62–1.11) | 0.22 |
Tumour p-STAT3 binary (positive vs. negative) | 0.66 (0.44–0.98) | 0.04 | 0.70 (0.43–1.15) | 0.16 |
Stroma p-STAT3 ordinala | 0.86 (0.67–1.09) | 0.20 | 0.92 (0.68–1.22) | 0.55 |
Stroma p-STAT3 binary (positive vs. negative) | 0.75 (0.52–1.09) | 0.13 | 0.82 (0.52–1.30) | 0.39 |
ER+/HER2+ | ||||
Tumor p-STAT3 ordinala | 1.09 (0.66–1.80) | 0.73 | 0.86 (0.40–1.85) | 0.71 |
Tumor p-STAT3 binary (positive vs. negative) | 1.33 (0.56–3.21) | 0.52 | 1.34 (0.45–3.93) | 0.60 |
Stroma p-STAT3 ordinala | 0.86 (0.49–1.52) | 0.61 | 0.78 (0.36–1.67) | 0.52 |
Stroma p-STAT3 binary (positive vs. negative) | 0.93 (0.41–2.12) | 0.86 | 0.79 (0.27–2.34) | 0.67 |
Ordinal indicates 4 categories for immunohistochemistry, i.e., 0, 0.1–10, 10.1–100, >100; bold font indicates statistical significance. p-STAT3, phosphorylated-signal transducer and activator of transcription 3; ER, estrogen receptor; DFS, disease-free survival; OS, overall survival.